Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Herman Kao

Dentist, Oral and Maxillofacial Surgery Fort Worth, TX Doctor of Dentistry

NPI 1598968190 CMS profile 72635

1625 Saint Louis Ave., Fort Worth, TX 76104

Open in the dashboard

General payments

$41,008

175 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Herman Kao of Fort Worth, TX is reported in the CMS Open Payments database as having received $41,008 across 175 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,141 25
2024 General $2,049 29
2023 General $770 14
2022 General $13,451 49
2021 General $275 9
2020 General $9,559 16
2019 General $11,762 33

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Herman Kao
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Herman Kao were reported at $3,141. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Herman Kao Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $11,762 $142 $50–$420 $163
2020 $9,559 $96 $36–$277 $114
2021 $275 $138 $45–$419 $132
2022 $13,451 $144 $48–$367 $149
2023 $770 $153 $55–$399 $160
2024 $2,049 $152 $50–$400 $164
2025 $3,141 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $24,579 15 payments
  2. CMF Medicon Surgical Inc. $5,400 1 payment
  3. KLS-Martin L.P. $3,650 35 payments
  4. Nobel Biocare USA $2,229 53 payments
  5. Straumann USA LLC $2,077 28 payments
  6. BioHorizons Implant Systems Inc. $2,014 27 payments
  7. Keystone Dental Inc. $437 4 payments
  8. Baxter Healthcare $226 6 payments
  9. Geistlich Pharma, North America, Inc. $148 2 payments
  10. Salvin Dental Specialties, Inc. $87 1 payment
  11. Other $161 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $24,366 11 payments
  2. Consulting Fee $5,400 1 payment
  3. Food and Beverage $5,378 149 payments
  4. Travel and Lodging $3,182 8 payments
  5. Honoraria $2,000 1 payment
  6. Entertainment $397 3 payments
  7. Gift $286 2 payments
Products named General payments · program years 2019–2025
  1. Omni Max $18,911 8 payments
  2. OMNIMAX $5,455 3 payments
  3. BIOHORIZONS Implant Dentistry $1,820 22 payments
  4. BIOHORIZONS Implant Dentistry $1,820 22 payments
  5. BIOHORIZONS Implant Dentistry $1,820 22 payments
  6. BIOHORIZONS Implant Dentistry $1,820 22 payments
  7. BIOHORIZONS Implant Dentistry $1,820 22 payments
  8. NOBELPARALLEL $1,777 28 payments
  9. NOBELACTIVE $1,777 28 payments
  10. NOBELREPLACE $239 8 payments
  11. Other $1,450 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

382

Median for Oral Surgery (Dentist only): 288

Drug cost

$1,297

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

28.8%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 131 $514
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 85 $342
Amoxicillin Generic 116 $236
Acetaminophen-Codeine Acetaminophen With Codeine Brand 25 $79
Clindamycin Hcl Generic 13 $68
Ciprofloxacin Hcl Generic 12 $58

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$4,431

Medicare's payments for the services billed

Medicare patients

14

Average age 72

Services billed

18

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Heart failure 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

175 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record